Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Airport Dimensions, the global leader in airport experiences, is significantly strengthening its footprint across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results